Elhini Ahmed, Abdelwahab Soha, Ikeda Katsuhisa
Department of Otorhinolaryngology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.
Laryngoscope. 2006 Mar;116(3):446-50. doi: 10.1097/01.mlg.0000194692.51979.d1.
Heme oxygenase (HO) is considered to be an antioxidant enzyme that catabolizes heme to produce carbon monoxide (CO) and biliverdin. Three isoforms of HO have been discovered. Recently, HO-1 has been found to be upregulated after allergic inflammations of the lower airway.
The objective of this study was to address the expression of HO isoenzymes 1 and 2 in the nasal mucosa of patients with allergic rhinitis as well as normal control subjects.
Nasal mucosa from 30 patients with persistent allergic rhinitis as well as from 10 normal volunteers was used in this study. We used immunofluorescent technique, Western blotting, and real-time quantitative polymerase chain reaction to localize and quantify the expression of these isoenzymes in normal and allergic human nasal tissues.
We found that HO-1 is expressed in the epithelial cells of seromucinous glands and macrophages with significant upregulation of its glandular expression in allergic rhinitis but with no difference in its macrophage expression between the study groups in contrast to HO-2 that is expressed in the vascular endothelial lining cells as well as macrophages with no marked difference between the study groups.
We demonstrated that expression of HO-1, but not HO-2, was upregulated within the nasal tissues in allergic rhinitis inflammation, and understanding the induction of HO-1 expression may provide for better management of allergic rhinitis that involves oxidative stress.
血红素加氧酶(HO)被认为是一种抗氧化酶,可分解血红素生成一氧化碳(CO)和胆绿素。已发现HO有三种同工型。最近,发现HO-1在下呼吸道过敏性炎症后上调。
本研究的目的是探讨HO同工酶1和2在变应性鼻炎患者以及正常对照者鼻黏膜中的表达情况。
本研究使用了30例持续性变应性鼻炎患者以及10名正常志愿者的鼻黏膜。我们采用免疫荧光技术、蛋白质印迹法和实时定量聚合酶链反应来定位和定量这些同工酶在正常和变应性人鼻组织中的表达。
我们发现HO-1在浆液性腺上皮细胞和巨噬细胞中表达,在变应性鼻炎中其腺表达显著上调,但研究组之间其巨噬细胞表达无差异,而HO-2在血管内皮衬里细胞以及巨噬细胞中表达,研究组之间无明显差异。
我们证明,在变应性鼻炎炎症中,鼻组织内HO-1的表达上调,而HO-2未上调,了解HO-1表达的诱导情况可能有助于更好地管理涉及氧化应激的变应性鼻炎。